Cervical Lymph Nodes and Unknown Primary Tumor of the Head and Neck

Primary Site Histology Schema Discriminator 1
C760 8010, 8046, 8051-8052, 8070-8074, 8082-8084, 8121, 8140, 8147, 8200, 8310, 8430, 8450, 8480, 8525, 8550, 8562, 8941 2, 3, 4, 5

Notes

8010, 8046, 8051-8052, 8070-8074, 8082-8084, 8121, 8140, 8147, 8200, 8310, 8430, 8450, 8480, 8525, 8550, 8562, 8941 Schema Discriminator 1 Occult Head and Neck Lymph Nodes: 2, 3, 4, 5 C760 Head, face & neck, NOS **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 6 *Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** *Schema Discriminator 1: Occult Head and Neck Lymph Nodes* is used to discriminate between Cervical Lymph Nodes and Unknown Primary Tumor of the Head and Neck, Ill-Defined Other and Soft Tissue Other when primary site is C760. **Note 3:** See the following schemas for the listed histologies * 8010, 8046, 8051-8052, 8070-8074, 8082-8084, 8121, 8140, 8147, 8200, 8310, 8430, 8450, 8480, 8525, 8550, 8562 (Schema Discriminator 1 Occult Head and Neck Lymph Nodes: 0,1): *Ill-defined Other* * 8941 (Schema Discriminator 1 Occult Head and Neck Lymph Nodes: 0, 1): *Soft Tissue Other* * 8710-8714, 8800-8934, 8940, 8950-9138, 9141-9582: *Soft Tissue Other* * 8935-8936: *GIST* * 9140: *Kaposi Sarcoma* * 9700-9701: *Mycosis Fungoides* **Note 4:** This schema applies when cervical lymph nodes are involved with cancer and the primary site is not known but is suspected to be in the head and neck, i.e., in one or more of the sites listed below. Cancer registry standard setters have agreed that such cancers should be coded to primary site code C760 to accommodate staging recommended by AJCC. * Lip: C000-C006, C008-C009 * Base of Tongue: C019 * Other and Unspecified Parts of Tongue: C020-C024, C028, C029 * Gum: C030-C031, C039 * Floor of Mouth: C040-C041, C048-C049 * Palate: C050-C052, C058-C059 * Other and Unspecified Parts of Mouth: C060-C062, C068-C069 * Parotid gland: C079 * Tonsil: C090-C91, C098-C099 * Oropharynx: C100-C104, C108-C109 * Nasopharynx: C110-C113, C118-C119 * Pyriform sinus: C129 * Hypopharynx: C130-C132. C138-C139 * Other and Ill-defined Sites in Lip, Oral Cavity and Pharynx: C140, C142, C148 * Nasal cavity: C300 * Middle ear: C301 * Accessory Sinuses: C310-C313, C318-C319 * Larynx: C320-C323, C328-C329 * Skin of lip: C440 * Skin of ear & external auricular canal: C442 * Skin of other & unspecified parts of face: C443 * Skin of scalp & neck: C444 **Note 5:** If the physician indicates that the metastatic cervical lymph node is most likely from a head and neck primary, then code primary site as C760. If the differential diagnosis includes non-head and neck sites, for example, the path report states metastasis to the cervical lymph node could be from a head and neck primary, lung primary, or gynecologic primary OR if there is no information indicating origin of primary tumor, then code primary site as C809 (Ill Defined Other)

Data Items

Name Default Value Used for Staging NAACCR Item Required By Metadata
Year of Diagnosis <BLANK> No NAACCR #390
dateOfDiagnosis
None
Primary Site <BLANK> Yes NAACCR #400
primarySite
None
Histology <BLANK> Yes NAACCR #522
histologicTypeIcdO3
None
Behavior <BLANK> Yes NAACCR #523
behaviorCodeIcdO3
None
Schema Discriminator 1 <BLANK> Yes NAACCR #3926
schemaDiscriminator1
All SSDI
Tumor Size Clinical 000 No NAACCR #752
tumorSizeClinical
None
Tumor Size Pathological 000 No NAACCR #754
tumorSizePathologic
None
Tumor Size Summary 000 No NAACCR #756
tumorSizeSummary
None
Regional Nodes Positive 99 No NAACCR #820
regionalNodesPositive
None
Regional Nodes Examined 99 No NAACCR #830
regionalNodesExamined
None
LVI 8 No NAACCR #1182
lymphVascularInvasion
None
RX Summ Surgery/Radiation Sequence <BLANK> No NAACCR #1380
rxSummSurgRadSeq
None
RX Summ Systemic/Surgery Sequence <BLANK> No NAACCR #1639
rxSummSystemicSurSeq
None
EOD Primary Tumor 800 Yes NAACCR #772
eodPrimaryTumor
None
EOD Regional Nodes 999 Yes NAACCR #774
eodRegionalNodes
None
EOD Mets 00 Yes NAACCR #776
eodMets
None
SS2018 <BLANK> No NAACCR #764
summaryStage2018
None
Grade Clinical 9 No NAACCR #3843
gradeClinical
CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Pathological 9 No NAACCR #3844
gradePathological
CCCR/Canada
COC
NPCR
SEER
SSDI
Grade Post Therapy Clin (yc) <BLANK> No NAACCR #1068
gradePostTherapyClin
COC
NPCR
SEER
SSDI
Grade Post Therapy Path (yp) <BLANK> No NAACCR #3845
gradePostTherapy
CCCR/Canada
COC
NPCR
SEER
SSDI
Extranodal Exten H&N Clin 8 No NAACCR #3831
extranodalExtensionHeadNeckClin
COC
SEER (RC)
SSDI
Extranodal Exten H&N Path X.8 No NAACCR #3832
extranodalExtensionHeadNeckPath
CCCR/Canada
COC
SEER
SSDI
Lymph Nodes Size of Mets XX.8 No NAACCR #3883
lnSize
CCCR/Canada
COC
SEER
SSDI
Lymph Nodes H&N Lev I-III 8 No NAACCR #3876
lnHeadAndNeckLevels1To3
COC
SEER
SSDI
Lymph Nodes H&N Lev IV-V 8 No NAACCR #3877
lnHeadAndNeckLevels4To5
COC
SEER
SSDI
Lymph Nodes H&N Lev VI-VII 8 No NAACCR #3878
lnHeadAndNeckLevels6To7
COC
SEER
SSDI
Lymph Nodes H&N Other 8 No NAACCR #3879
lnHeadAndNeckOther
COC
SEER
SSDI

Initial Context

Staging Methods

Expand All | Collapse All

Summary Stage 2018

Start

Additional Context
eod_2018_t = 90
eod_2018_n = 90
eod_2018_m = 90

Next Step

  1. EOD Primary Tumor
  2. ss2018_t

Next Step

  1. EOD Regional Nodes
  2. ss2018_n

Next Step

  1. EOD Mets
  2. ss2018_m

Next Step

  1. Summary Stage
  2. ss2018_derived

End

Outputs

Name Default Value Description NAACCR Item Metadata
Schema ID 00060 NAACCR #3800
schemaId
None
Derived Version {{ctx_alg_version}} None None
Derived Summary Stage 2018 9 NAACCR #762
derivedSummaryStage2018
None